NCCN issues first guidelines for deep vein thrombosis treatment in cancer patients

J Natl Cancer Inst. 2006 Apr 19;98(8):515. doi: 10.1093/jnci/djj175.
No abstract available

Publication types

  • News

MeSH terms

  • Anticoagulants / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Drug Administration Schedule
  • Fondaparinux
  • Government Agencies
  • Heparin / administration & dosage
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / surgery*
  • Polysaccharides / administration & dosage
  • Practice Guidelines as Topic
  • Surgical Procedures, Operative / adverse effects
  • United States
  • Venous Thrombosis / complications
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / drug therapy*
  • Venous Thrombosis / etiology*
  • Venous Thrombosis / prevention & control

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Polysaccharides
  • Heparin
  • Fondaparinux